NEW DELHI (ANI) – The US Food and Drug Administration has completed the inspection of the multipurpose API manufacturing facility of Solara Active Pharma Sciences Limited at Visakhapatnam. The ...
Here's an analysis of the annual report of SOLARA ACTIVE PHARMA SCIENCES for 2024-25. It includes a full income statement, balance sheet and cash flow analysis of SOLARA ACTIVE PHARMA SCIENCES. Also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results